aristolochic acid i has been researched along with fura-2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jan, CR; Tseng, CJ | 1 |
Chang, HT; Chen, IS; Chou, CT; Ho, CM; Huang, JK; Jan, CR; Kuo, CC; Liao, WC; Lin, KL; Liu, SI; Lu, YC; Shu, SS; Tsai, JY; Wang, JL | 1 |
2 other study(ies) available for aristolochic acid i and fura-2
Article | Year |
---|---|
W-7 induces [Ca(2+)](i) increases in Madin-Darby canine kidney (MDCK) cells.
Topics: Animals; Aristolochic Acids; Calcium; Calcium Signaling; Calmodulin; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; Fluorescence; Fura-2; Hydrazones; Kidney; Phenanthrenes; Propranolol; Pyrrolidinones; Sulfonamides; Thapsigargin; Time Factors | 2000 |
Effect of thapsigargin on Ca²+ fluxes and viability in human prostate cancer cells.
Topics: Apoptosis; Aristolochic Acids; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Estrenes; Fluorescence; Fura-2; Humans; Intracellular Space; Male; Manganese; Prostatic Neoplasms; Pyrrolidinones; Thapsigargin; Type C Phospholipases | 2011 |